Pfizer plans to pay $229 per share in cash for Seagen, whose stock soared more than 15% in trading on Monday afternoon. Pfizer’s shares gained about 1.7%.
You are here: Home / Top Stories / : Pfizer’s $43 billion bid for Seagen aims to broaden company’s cancer portfolio